Genetic testing for inherited vulnerability for breast and ovarian cancer is the first genetic test to be marketed openly to consumers. Public health agencies might be called upon to respond issues regarding this testing from the wide-ranging public and healthcare providers in their communities. This truth sheet holds information regarding the genetic test for inherited vulnerability for breast and ovarian cancer, the clinical perspective in which it is presently employed, and a number of the possible ethical and social matters.
More: continued here
No Comments so far ↓
There are no comments yet...Kick things off by filling out the form below.